Tax Smarter, Not Harder: The Case for Risk-Proportionate Nicotine Taxation

Smoking kills roughly 480,000 Americans each year. After decades of public health campaigns and aggressive taxation, millions of adults still smoke—and most wish they could stop. But what if the tax code itself is part of the problem?

State legislatures across the country are rushing to tax e-cigarettes, nicotine pouches, heated tobacco, and snus at rates comparable to cigarettes. The instinct is understandable; however, the science says it is dangerously wrong. A smarter framework that taxes products in proportion to their actual risk could save thousands of lives.

Not All Nicotine Products Are Equal

The harm from tobacco comes overwhelmingly from combustion. Cigarette smoke contains more than 7,000 chemicals, including at least 70 known carcinogens. While addictive, nicotine is not the primary driver of disease. Products that deliver nicotine without combustion are fundamentally different.

An expert independent evidence review conducted by Public Health England concluded that e-cigarettes are approximately 95 percent less harmful than combustible cigarettes. The U.S. Food and Drug Administration (FDA) recognizes a “continuum of risk” for nicotine products. In January 2025, the agency authorized 20 ZYN nicotine pouch products after finding them “appropriate for the protection of public health.”

Sweden offers compelling real-world proof. Thanks to widespread use of snus and nicotine pouches, Sweden has cut its daily smoking rate to just 5.3 percent—the lowest in Europe—with 61 percent lower lung cancer death rates among men than the European average. Researchers estimate snus saves roughly 3,000 Swedish lives every year.

A Wave of Misguided Tax Bills

Despite this evidence, states are moving in the opposite direction. In 2025 alone, legislators in at least 20 states introduced bills to tax nicotine pouches, and the pace is accelerating in 2026.

• New York: Gov. Kathy Hochul’s FY 2027 budget proposal would apply a 75 percent wholesale tobacco tax to nicotine pouches to match the existing tax imposed on cigarettes in a state that already levies the highest cigarette tax in the nation at $5.35 per pack.
• Utah: HB 337 proposes an 86 percent manufacturer’s price tax on alternative nicotine products while simultaneously repealing a tax reduction for FDA-authorized modified-risk tobacco products.
• West Virginia: SB 392, which passed the state senate in February 2026, would sharply increase the excise tax on vapor products, raising the rate on closed-system cartridges to $1.20 each and open systems to $0.25 per milliliter (up from $0.075 cents) to help offset a 10 percent personal income tax cut.

The Evidence Against Flat Taxation

When states tax reduced-risk products at cigarette rates, consumers reasonably infer that the government views them as equally harmful. A peer-reviewed study of Minnesota’s 95 percent wholesale tax on e-cigarettes found that 32,400 additional adult smokers would have quit had the tax not existed. Nationally, cigarette-level e-cigarette taxes could deter more than 2.75 million smokers from quitting over a decade, and 1.9 additional cigarette packs are sold for every e-cigarette pod eliminated by a tax. These effects fall hardest on members of low-income households—the very population that would benefit most from affordable alternatives.

A Better Model: Risk-Proportionate Taxation

The principle is straightforward: Products that pose greater harm should bear greater tax. We already practice this—nicotine replacement therapies carry no excise tax, while cigarettes are taxed heavily. Risk-proportionate taxation simply extends that logic across the full nicotine spectrum.

Consider a proposed tiered framework for states seeking additional tax revenue— 

• Cigarettes: Taxed at full rate
• Very low nicotine cigarettes and loose tobacco: Taxed at 50 percent or less
• Heated or moist smokeless tobacco: Taxed at 25 percent or less
• Vapor products and modern oral nicotine: Taxed at 10 percent or less
• FDA-approved cessation therapies: Tax exempt

A study in the International Journal of Environmental Research and Public Health tested this exact structure and found it effectively incentivized smokers to substitute less harmful products without increasing total nicotine consumption, concluding that “differential taxation in proportion to product risk would be an effective way to incentivize smokers to switch from smoked to low-risk, unsmoked types of tobacco.”

Conclusion

Tax policy should be guided by science, not the assumption that all nicotine is the same. Cigarettes should remain heavily taxed, while lower-risk products should be taxed at a lower rate. The millions of Americans searching for a way out should not be penalized by a tax code that treats their escape route the same as the thing that is killing them. States that get this right will not only collect revenue, they will also save lives.